OB/GYN 1608 - OB/GYN Clinical Alert - Aug 01, 2012

Target Audience:

This activity is intended for the obstetrician and gynecologist.

Accreditation:

AHC Media is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Credit Designation:

AHC Media designates this enduring material for a maximum of 2.0 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Faculty

Editor
Jeffrey T. Jensen, MD, MPH
Leon Speroff
Professor and Vice Chair for Research
Department of Obstetrics and Gynecology
Oregon Health and Science University
Portland

Peer Reviewer
Catherine Leclair, MD
Associate Professor
Department of OB/GYN
Oregon Health & Science University
Portland

Executive Editor
Leslie G. Coplin
AHC Media

Managing Editor
Neill L. Kimball
AHC Media

Associate Editors
Rebecca H. Allen, MD, MPH
Assistant Professor
Department of Obstetrics and Gynecology
Warren Alpert Medical School of Brown University
Women and Infants Hospital
Providence, RI

Robert L. Coleman, MD
Professor
University of Texas
M.D. Anderson Cancer Center
Houston

John C. Hobbins, MD
Professor
Obstetrics and Gynecology
University of Colorado School of Medicine
Aurora, CO

Frank W. Ling, MD
Clinical Professor
Departments of Obstetrics and Gynecology
Vanderbilt University School of Medicine
Meharry Medical College
Nashville

Subjects:

  • Long-Acting Reversible Contraception
  • PARP Inhibitor Maintenance SCORES in Ovarian Cancer
  • 10 Years after the WHI: Should This Study Guide Our Thinking About Menopausal Hormone Therapy?
  • Antenatal Steroids and Fetal Lung Maturity
  • Patient Attitudes Toward Treatments for Overactive Bladder

Objectives:

  • Explain the latest data regarding diagnosis and treatment of various diseases affecting women
  • Discuss new data concerning prenatal care, neonatal health, and complications arising in pregnancy and the perinatal period
  • Discuss the advantages, disadvantages, and cost-effectiveness of new testing procedures in women?s health

Financial Disclosure:

OB/GYN Clinical Alert’s Editor, Jeffrey T. Jensen, MD, MPH, is a consultant Agile Pharmaceuticals, Bayer Healthcare, HRA Pharma, and Merck, is a speaker for Bayer Healthcare and Merck; and receives research support from Abbott Pharmaceuticals, Bayer Healthcare, HRA Pharma, and Medicines-360. Peer Reviewer Catherine LeClair, MD, Executive Editor Leslie G. Coplin, Managing Editor Neill Kimball, Associate Editors Rebecca H. Allen, MD, MPH, Robert L. Coleman, MD, and John C. Hobbins, report no financial relationship to this field of study.

Copyright 2012 AHC Media. All rights reserved.